US Broker Ratings

BioNTech SE (BNTX) Investor Outlook: Potential 36.52% Upside Amidst Growing Immunotherapy Portfolio

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, commands significant attention from investors owing to its pivotal role in developing cutting-edge immunotherapies. With a current market capitalization..

Alkermes plc (ALKS) Stock Analysis: Growth Potential with a 28.20% Revenue Surge

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its specialty and generic pharmaceutical offerings. Headquartered in Dublin, Ireland,..

Cytokinetics, Inc. (CYTK) Stock Analysis: Tapping into a Potential 49% Upside in the Biotech Sector

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical leader in the healthcare sector, is capturing investor attention with its promising pipeline of novel muscle activators and inhibitors. As a biotechnology firm focused..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Biotech Gem with 41% Upside Potential

Investors in the biotechnology sector may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing proposition, particularly given its focus on addressing metabolic dysfunction-associated steatohepatitis (MASH) with innovative therapeutics like Rezdiffra...

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 57% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is carving out a notable position in the healthcare sector, particularly within the medical devices industry. Headquartered in San Francisco, California, iRhythm is renowned for..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus Reveals a Striking 118.65% Potential Upside

Telix Pharmaceuticals Limited (TLX), a leading player in the biopharmaceutical sector, is gaining traction among investors due to its promising pipeline and significant growth potential. Headquartered in North Melbourne, Australia,..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthy 47.55% Upside Potential In Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, particularly in medical care facilities, stands out with its robust growth potential. With a market capitalization of..

Glaukos Corporation (GKOS) Stock Analysis: A 23% Upside Potential in the Booming Medical Device Market

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, has been capturing investor attention with its innovative solutions in the medical devices industry. As the company continues to..

Legend Biotech Corporation (LEGN): Investor Outlook with 60.57% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biopharmaceutical landscape with its impressive growth potential and innovative approach to oncology therapeutics. As a prominent player in the healthcare sector,..

Viatris Inc. (VTRS) Stock Analysis: Navigating Growth Prospects with an 8.09% Potential Upside

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is making waves in the stock market with its recent performance and growth potential. Operating within the Drug Manufacturers –..

Novo Nordisk A/S (NVO) Stock Analysis: Assessing Growth Potential and Dividend Attraction

Novo Nordisk A/S (NVO), a dominant player in the global healthcare sector, continues to make significant strides in the drug manufacturing industry. With a robust market capitalization of $194.35 billion,..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth with a 7.98% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) presents a compelling opportunity for investors keen on the healthcare sector, specifically within biotechnology. With a robust market capitalization of $31.6 billion, Royalty Pharma stands..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX): Investor Outlook on a Medical Device Innovator with a 60.17% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), with a market capitalization of $2.52 billion, stands at the forefront of transforming organ transplant therapy. Known for its pioneering Organ Care System (OCS), the..

Quest Diagnostics Incorporated (DGX) Stock Analysis: A 10% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing prospect. With a market capitalization of $22.48 billion, Quest Diagnostics is a leading player..

Guardant Health, Inc. (GH) Stock Analysis: Cutting-edge Diagnostics with a 7% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the precision oncology space, offering a suite of cutting-edge diagnostic tests that are reshaping cancer detection and research...

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 36.83% Upside in the Thriving Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) is making waves in the healthcare sector with its innovative solutions for musculoskeletal disorders. With a market capitalization of $10.91 billion, Globus Medical stands as..

Natera, Inc. (NTRA) Stock Analysis: Evaluating a 22.62% Potential Upside in the Diagnostics Arena

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is gaining attention from the investor community thanks to its impressive revenue..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services

For investors keen on opportunities within the healthcare sector, Doximity, Inc. (NYSE: DOCS) presents a compelling case. Headquartered in San Francisco, Doximity operates a thriving digital platform tailored for medical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds